Washington, DC, United States of America

Shabnum Patel

This inventor holds 1 USPTO granted patent. Top assignee: Children's National Medical Center. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shabnum Patel. Retrieved from https://idiyas.com/inventor/shabnum-patel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shabnum Patel: Innovator in Mycobacterial Research

Introduction

Shabnum Patel is a notable inventor based in Washington, DC. He has made significant contributions to the field of medical research, particularly in the area of mycobacterial antigen compositions.

Latest Patents

Shabnum Patel holds one patent titled "Mycobacterial antigen compositions and methods of use." This patent relates to mycobacterial polynucleotides and polypeptides, including their fragments or variants. It also involves cells engineered to expand T-cells ex vivo, along with methods of use for these compositions.

Career Highlights

Shabnum Patel is affiliated with the Children's National Medical Center, where he applies his expertise in medical research. His work focuses on advancing the understanding and treatment of diseases related to mycobacteria.

Collaborations

He collaborates with esteemed colleagues, including Michael Keller and Catherine M Bollard, to further enhance the impact of his research.

Conclusion

Shabnum Patel's innovative work in mycobacterial research exemplifies the importance of scientific advancements in medicine. His contributions are paving the way for new therapeutic approaches.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…